Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Sep;169(2):150-60.
doi: 10.1007/s00213-003-1483-1. Epub 2003 May 27.

Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential

Affiliations

Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential

John N Bain et al. Psychopharmacology (Berl). 2003 Sep.

Abstract

Rationale: One of the common neurochemical features of many drugs of abuse is their ability to directly or indirectly enhance dopaminergic activity in the brain, particularly within the ventral tegmental-nucleus accumbens pathway. Dopaminergic pathways in the frontal and limbic cortex also may be targets for these agents, where pharmacological effects could result in heightened attention and/or support self-administration behavior.

Objectives: The purpose of this study was to determine whether drugs from differing pharmacological classes that exhibit abuse potential would share the ability to counter distractability in the delayed matching task.

Methods: Well trained mature macaques performed a computer-assisted delayed matching-to-sample task which included trials associated with three delay intervals and randomly interspersed task-relevant distractors. Drug regimens included four to five doses and subjects were tested no more than twice per week.

Results: All but one of the six compounds (tomoxetine), on average, increased task accuracy for either non-distractor or distractor trials. It was evident that for several compounds, doses required to improve accuracy for non-distractor trials were routinely greater than the doses required to improve accuracy for distractor trials. Data for the individualized Best dose (based upon the subject's optimal level of accuracy during distractor trials) revealed statistically significant distractor-related improvements in task accuracy for the same five compounds. The relative efficacy for reversing distractor-induced decrements in task accuracy was estimated by the level of improvement with respect to baseline: nomifensine (31%)>nicotine (22%) approximately morphine (19%) approximately caffeine (19%) approximately methylphenidate (22%) >tomoxetine (9%). Tomoxetine (noradrenergic preferring) was the only compound that did not produce a significant improvement in accuracy.

Conclusions: These results provide pharmacological support for the concept that attentional mechanisms may play an important role in the "environmental" associative aspects of drug seeking behavior, and as such they may provide the basis for treatment strategies aimed at preventing relapse in detoxified addicts.

PubMed Disclaimer

References

    1. Br J Clin Pharmacol. 1977;4Suppl 2:159S-163S - PubMed
    1. Psychopharmacology (Berl). 1998 Mar;136(1):50-8 - PubMed
    1. J Pharmacol Exp Ther. 1991 Sep;258(3):857-65 - PubMed
    1. Eur J Pharmacol. 1976 Aug;38(2):281-91 - PubMed
    1. Neurotoxicol Teratol. 2000 Jul-Aug;22(4):487-502 - PubMed

Publication types

MeSH terms